Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Jan;37(1):126–129. doi: 10.1038/bjc.1978.18

Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.

L Mussoni, A Poggi, G De Gaetano, M B Donati
PMCID: PMC2009508  PMID: 23140

Full text

PDF
126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atherton A., Busfield D., Hellman K. The effects of an antimetastatic agent, (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ICRF 159), on platelet behavior. Cancer Res. 1975 Apr;35(4):953–957. [PubMed] [Google Scholar]
  2. Gasic G. J., Gasic T. B., Murphy S. Anti-metastatic effect of aspirin. Lancet. 1972 Oct 28;2(7783):932–933. doi: 10.1016/s0140-6736(72)92581-0. [DOI] [PubMed] [Google Scholar]
  3. Gasic G. J., Gasic T. B., Stewart C. C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968 Sep;61(1):46–52. doi: 10.1073/pnas.61.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hilgard P., Heller H., Schmidt C. G. The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL). Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Aug 30;86(3):243–250. doi: 10.1007/BF00286943. [DOI] [PubMed] [Google Scholar]
  5. Hilgard P. The role of blood platelets in experimental metastases. Br J Cancer. 1973 Nov;28(5):429–435. doi: 10.1038/bjc.1973.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Karrer K., Humphreys S. R., Goldin A. An experimental model for studying factors which influence metastasis of malignant tumors. Int J Cancer. 1967 May 15;2(3):213–223. doi: 10.1002/ijc.2910020303. [DOI] [PubMed] [Google Scholar]
  7. Kolenich J. J., Mansour E. G., Flynn A. Haematological effects of aspirin. Lancet. 1972 Sep 30;2(7779):714–714. doi: 10.1016/s0140-6736(72)92124-1. [DOI] [PubMed] [Google Scholar]
  8. Mussoni L., Poggi A., Donati M. B., de Gaetano G. Ditazole and platelets III. Effect of ditazole on tumor-cell induced thrombocytopenia and on bleeding time in mice. Haemostasis. 1977;6(4):260–265. doi: 10.1159/000214188. [DOI] [PubMed] [Google Scholar]
  9. Patrono C., Ciabattoni G., Crossi-Belloni D. Release of prostaglandin F1alpha and F2alpha from superfused platelets: quantitative evaluation of the inhibitory effects of some aspirin-like drugs. Prostaglandins. 1975 Apr;9(4):557–568. doi: 10.1016/0090-6980(75)90061-1. [DOI] [PubMed] [Google Scholar]
  10. Poggi A., Donati M. B., Polentarutti N., de Gaetano G., Garattini S. On thrombocytopenia developing in mice bearing a spontaneously metastasizing tumor. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976 Aug 30;86(3):303–306. doi: 10.1007/BF00286949. [DOI] [PubMed] [Google Scholar]
  11. Poggi A., Polentarutti N., Benedetta Donati M., de Gaetano G., Garattini S. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res. 1977 Jan;37(1):272–277. [PubMed] [Google Scholar]
  12. Santoro M. G., Philpott G. W., Jaffe B. M. Inhibition of tumour growth in vivo and in vitro by prostaglandin E. Nature. 1976 Oct 28;263(5580):777–779. doi: 10.1038/263777a0. [DOI] [PubMed] [Google Scholar]
  13. Simpson-Herren L., Lloyd H. H. Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother Rep. 1970 Jun;54(3):143–174. [PubMed] [Google Scholar]
  14. Wood S., Jr Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants. J Med. 1974;5(1):7–22. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES